{"id":10728,"date":"2023-10-20T14:08:40","date_gmt":"2023-10-20T18:08:40","guid":{"rendered":"https:\/\/www.med.unc.edu\/urology\/?p=10728"},"modified":"2023-10-20T14:17:01","modified_gmt":"2023-10-20T18:17:01","slug":"dr-marc-bjurlin-takes-the-stage-in-florence-italy-at-the-8th-annual-european-conference-on-tobacco-control","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/urology\/dr-marc-bjurlin-takes-the-stage-in-florence-italy-at-the-8th-annual-european-conference-on-tobacco-control\/","title":{"rendered":"Dr. Marc Bjurlin Takes the Stage in Florence, Italy at the 8th Annual European Conference on Tobacco Control"},"content":{"rendered":"

ºÚÁÏÍø Urology is proud to announce the distinguished participation of Dr. Marc Bjurlin<\/a>, Associate Professor of Urology, at the 8th Annual European Conference on Tobacco Control (ECTC)<\/a> hosted by the European Network for Smoking and Tobacco Prevention (ENSP)<\/a>. This year, the conference convened in the picturesque city of Florence, Italy, bringing together experts from around the globe to discuss critical issues in tobacco control.<\/p>\n

About the Event: ECTC 2023<\/h2>\n

The ECTC is a significant platform for dialogue and collaboration in the realm of tobacco control. This year, Dr. Bjurlin was honored with an invitation to lead a plenary lecture focusing on the intricate relationship between smoking and bladder cancer.<\/p>\n

Dr. Bjurlin\u2019s involvement went beyond delivering a lecture. He helped curate a comprehensive session, featuring an international lineup of speakers. This esteemed panel included Dr. Jose Nolazco (Harvard University), Dr. Richard Matulewicz (Memorial Sloan Kettering Cancer Center), Dr. Krzysztof Przewozniak (Maria Sklodowska-Curie National Research Institute of Oncology), Prof. Francesco Soria (University of Torino School of Medicine), and Mrs. Jacqueline Daly (Cancer Patients Europe).<\/p>\n

The focal point of Dr. Bjurlin\u2019s talk was \u201cE-cigarettes use and the risk of bladder cancer<\/em>.\u201d Drawing from his extensive academic research and clinical experience, he provided a nuanced perspective on the alarming rise in e-cigarette use in the United States. His talk delved into the toxic and carcinogenic compounds associated with e-cigarette use, their links to bladder cancer, and DNA changes that have been observed in mice models exposed to e-cigarette vapor.<\/p>\n

ºÚÁÏÍø Urology congratulates Dr. Bjurlin on his impactful participation at the ECTC 2023, representing our commitment to advancing knowledge and improving patient outcomes in urologic oncology on a global scale.
\n

\n
\n\"\"<\/a><\/div>\n
\n\"\"<\/a><\/div>\n
\n\"\"<\/a>\n<\/div>\n
\n<\/div>\n<\/div>\n

 <\/p>\n